Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsStridespharmascience

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Stride Arcolab, says Sukhani

      Sudarshan Sukhani, s2analytics.com is of the view that one can buy Stride Arcolab.

    • Super Six: Top chart picks for today

      On CNBC-TV18's show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment, Nooresh Mirani, AMSEC and Vishal B Malkan, CMT, www.malkansview.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Bull's Eye: 12 stocks you can bet on Nov 4

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Yes Bank, Lanco, ABG Shipyard good picks: Anantakrishnan

      Yes Bank, Lanco and ABG Shipyard are good picks, says TS Anantakrishnan, Director, Prime Broking.

    • Stride Arcolab has target of Rs 352: Aashish Tater

      Stride Arcolab has target of Rs 352, says Aashish Tater of Fort Share Broking.

    • Bull's Eye: Buy Pipavav, VIP, Gitanjali Gema; short Sun TV

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Stride Arcolab, says Sharmila Joshi

      Buy Stride Arcolab, says Sharmila Joshi of Fairwealth Securities.

    • Bull's Eye: Short Sesa Goa, Educomp, Sterlite Ind; buy Eros

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Book profit in Stride Arcolab: Ashish Chaturmohta

      Book profit in Stride Arcolab, says Ashish Chaturmohta of IIFL Wealth.

    • Stride Arcolab has target of Rs 475: PN Vijay

      Stride Arcolab has target of Rs 475, says PN Vijay, Portfolio Manager.

    • Pharma stocks look good: Sekhar

      Pharma stocks look good, says Phani Sekhar, Fund Manager, Angel Broking.

    • Buy Strides Arcolab: Jain

      Buy Stride Arcolab with a target of Rs 400, says Rajesh Jain, Independent Market Strategist.

    • Bull's Eye: 16 stocks you would want to know about

      Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.

    • Glenmark, Strides Acrolab top picks among pharma pack: Jain

      Glenmark, Strides Acrolabs top picks among pharma sector, says Rajesh Jain, Independent Market Strategist.

    • Sekhar upbeat on Stride Arcolab, Subros

      Phani Sekhar of Angel Broking upbeat on Stride Arcolab and Subros.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347